1.
Arozal W, Watanabe K, Veeraveedu PT, Ma M, Nafrialdi N. Telmisartan inhibits the progression of cardiomyopathy in daunorubicin treated rats: the role of advanced glycation end products. Med J Indones [Internet]. 2011Nov.1 [cited 2024Dec.4];20(4):255-62. Available from: http://mji.ui.ac.id/journal/index.php/mji/article/view/461